Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Unit to Fund Research at U of Michigan to Develop New Genomic, Proteomic Technologies

NEW YORK, Oct. 12 (GenomeWeb News) - Fisher Biosciences, a unit of Fisher Scientific, will collaborate with the Universityof Michiganto develop new tools for genomic and proteomic research, the company said today.

 

Under the five-year agreement, Fisher will financially support research projects at the Center for Chemical Genomics, a new center that is part of the university's Life Sciences Institute. Technologies to be developed are in the areas of high-throughput screening and detection, protein expression, chemical diversity, and bioinformatics.

 

In exchange for the funding, Fisher will have the opportunity to license new technologies resulting from the research.

 

Fisher said it is targeting the development of new procedures for protein testing and sample preparation, new ways of using RNA-interference products, and broader applications of high-content screening.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.